ArticleTrials2022

Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial-an update.

Felix Nägele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.